On the other hand, we reported that a diet containing 2 % powdered fronds of Undaria pinnatifida (U. pinnatifida) inhibits 1,2-dimethylhydrazine (DMH)-induced intestinal tumorigenesis [13] . However, the same diet was ineffective against mammary tumorigenesis induced by 7,12-dimethylbenz[a]anthracene (DMBA) in rats [14] . Others have found that water extracts of Mekabu significantly delay DMBA-induced mammary carcinogenesis in rats [15] . The powdered fronds and water extracts of U. pinnatifida appear to have antitumor activity during the post-initiation phase of carcinogen-induced mammary cancer. However, the most potent agents and the mechanisms of action remain obscure.
We initially examined whether dietary Mekabu fucoidan has antitumor activity against A20 lymphoma cells and whether it modulates Th1 cell and NK cell responses. Food intake by the mice in each group as measured weekly throughout the experimental period showed no significant difference between the groups fed with fucoidan (3.4 ± 0.3 g) and with a basic diet (3.7 ± 0.3 g). Therefore, the total daily intake of fucoidan per mouse was 0. Our data suggest that Mekabu fucoidan augments Th1 cell and NK cell activities in Do-11 -10 mice. We examined whether the production of Th1 type cytokines (IFN-γ and IL-12) in T cells purified from the spleen is enhanced in Do-11 -10 mice fed with Mekabu fucoidan. The IFN-γ production of Mekabu fucoidan fed mice was significantly increased than that of the control mice ( Fig. [3] A). The amount of IL-12 in the T cell culture supernatants were essentially similar in the presence or absence of dietary Mekabu fucoidan (Fig. [3] B) . Nonetheless, a diet containing 1 % Mekabu fucoidan augments Th1 cell and NK activities.
Our observations indicate that fucoidan, a polysaccharide derived from U. pinnatifida, is a potent antitumor agent and that its mode of action is associated with the immune response. We postulate that U. pinnatifida extracts can activate NK cells during the post-initiation phase of cancer. Further study should elucidate the relationship between NK and dendritic cells in the antitumor activities of Mekabu fucoidan. 
(Student's t-test).

#
Materials and Methods
Mekabu fucoidan: Milled Mekabu (Jeollanam-do; Seoul, Korea), the sporophyll of U. pinnatifida; 1 kg was washed with 15 L of cold water (10 °C) for 2 min and extracted with 7 L of 10 μM HCl (pH 1) at room temperature for 15 h. The extract was centrifuged at 5,000 g for 10 min and the supernatant was passed through filter paper (No. 2; Whatman Japan K.K.; Tokyo, Japan) using Celite as filter aid. The filtrate was neutralized with 3 N NaOH and then ultrafiltered through ACP-1013 (MW: 6,000; Asahi Kasei Co. Ltd.; Tokyo, Japan) to obtain 93 g of lyophilized Mekabu fucoidan. The composition of Mekabu fucoidan was 15.6 % L-fucose, 20.7 % galactose, 8.2 % uronic acid, 23.0 % ester sulfate, and 32.5 % ash as a percentage of dry weight. The experimental diet containing 1 % Mekabu fucoidan was prepared at Oriental Yeast Co. Ltd. in the form of pellets by incorporating the fucoidan into the basic diet (MF: Oriental Yeast Co., Ltd.; Tokyo, Japan).
Experiment 1:
Male BALB/c mice (n = 10; Clea Japan Inc.; Tokyo, Japan) were housed under specific pathogen-free conditions and used at 6 weeks of age. We incorporated 1 % Mekabu fucoidan into a basic pelleted diet (MF; Oriental Yeast Co., Ltd.; Tokyo, Japan). Experimental mice were fed with either the basic diet or with the same diet containing Mekabu fucoidan for 10 days before inoculation s. c. with a suspension of 1 × 107 A20 lymphoma cells/mouse, and then both groups received the fucoidan diet ad libitum for 40 days. Control mice were similarly inoculated but received the basic diet throughout the experimental period. The tumor was measured and weighed. The tumor inhibition ratio (TIR) (%) was calculated as (C -T)/C × 100, where T is the mean tumor weight (g) of the treated group and C is that of the control group. For IFN-γ and IL-12 analyses, splenocytes were passed through a column containing sterilized nylon fiber (Wako Chemical Industries, Ltd; Osaka, Japan) (0.7 g/10 mL syringe) for 1 h at 37 °C in a 5 % CO2 atmosphere. Purified T cells at a density of 5 × 105 per mL in 0.2 mL of complete medium were seeded in each well of 96-well microtiter plates that had been coated overnight with anti-CD3 antibody (PharMingen; San Diego, CA, USA). The plates were incubated at 37 °C under a 5 % CO2 atmosphere for 48 h. Levels of IFN-γ and IL-12 in the culture supernatants were measured in triplicate using ELISA kits (ENDOGEN, Inc.; Woburn, MA, USA) according to the manufacturer's instructions. The color reaction was stopped and absorbance was measured at 450 nm (Micro Plate Reader MOR A4I; Tosoh; Tokyo, Japan).
All experiments described herein adhered to the National Institutes of Health guidelines for the use of experimental animals. The Animal Use Committee of the Kitasato University School of Allied Health Sciences also approved the experimental protocol before starting the study.
